{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:44:26Z","timestamp":1787233466917,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jaip.2022.06.030","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T21:41:50Z","timestamp":1656711710000},"page":"2977-2983.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Delayed-Type Heparin Allergy: Intravenous Tolerance Despite Inflammatory Skin Reaction After Subcutaneous Injection"],"prefix":"10.1016","volume":"10","author":[{"given":"Axel","family":"Trautmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Gr\u00e4n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Stoevesandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.06.030_bib1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1538-7836.2003.t01-7-00115.x","article-title":"High rate of skin complications due to low-molecular-weight heparins in pregnant women","volume":"1","author":"Bank","year":"2003","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jaip.2022.06.030_bib2","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0140-6736(12)60409-7","article-title":"Heparin-induced skin lesions","volume":"380","author":"Schindewolf","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.06.030_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.mcna.2010.03.003","article-title":"The complex clinical picture of side effects to anticoagulation","volume":"94","author":"Trautmann","year":"2010","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jaip.2022.06.030_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1398-9995.2006.01063.x","article-title":"Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux","volume":"61","author":"Harr","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.06.030_bib5","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0022-5223(03)00813-4","article-title":"Life-threatening anaphylactic shock caused by porcine heparin intravenous infusion during mitral valve repair","volume":"126","author":"Bottio","year":"2003","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jaip.2022.06.030_bib6","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1378\/chest.127.5.1857","article-title":"Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study","volume":"127","author":"Warkentin","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2022.06.030_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1503\/cmaj.081729","article-title":"Incidence and causes of heparin-induced skin lesions","volume":"18","author":"Schindewolf","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.jaip.2022.06.030_bib8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.iac.2009.04.006","article-title":"Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection","volume":"29","author":"Trautmann","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2022.06.030_bib9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0190-9622(89)70240-1","article-title":"Eczema-like, erythematous, infiltrated plaques: a common side effect of subcutaneous heparin therapy","volume":"21","author":"Klein","year":"1989","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2022.06.030_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2133.1990.tb01457.x","article-title":"Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction","volume":"123","author":"Bircher","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.06.030_bib11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs\u2014an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.06.030_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1710-1492-9-1","article-title":"Allergic anaphylaxis due to subcutaneously injected heparin","volume":"9","author":"Anders","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2022.06.030_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1378\/chest.119.1_suppl.64S","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2022.06.030_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.0105-1873.2003.0185a.x","article-title":"Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans","volume":"49","author":"Ludwig","year":"2003","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.06.030_bib15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1160\/TH05-05-0318","article-title":"Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides","volume":"94","author":"Ludwig","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaip.2022.06.030_bib16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4065\/mcp.2010.0346","article-title":"Low allergenic potential with fondaparinux: results of a prospective investigation","volume":"85","author":"Schindewolf","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2022.06.030_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.0105-1873.2004.0350j.x","article-title":"Intolerance of fondaparinux in a patient allergic to heparins","volume":"50","author":"Hirsch","year":"2004","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.06.030_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.0105-1873.2004.0426c.x","article-title":"Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux","volume":"51","author":"Hohenstein","year":"2004","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.06.030_bib19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1160\/TH05-04-0895","article-title":"Hypersensitivity to the pentasaccharide fondaparinux in patients with delayed-type heparin allergy","volume":"94","author":"Utikal","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaip.2022.06.030_bib20","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00228-013-1510-z","article-title":"Novel oral anticoagulants: clinical pharmacology, indications and practical considerations","volume":"69","author":"Harder","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2022.06.030_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/14740330902778180","article-title":"Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes","volume":"8","author":"Warkentin","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaip.2022.06.030_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nbt1407","article-title":"Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events","volume":"26","author":"Guerrini","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaip.2022.06.030_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1160\/TH05-03-0673","article-title":"Immediate type hypersensitivity after injection of nadroparin (Fraxiparin)","volume":"94","author":"Bekkenk","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaip.2022.06.030_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2146\/ajhp080059","article-title":"Drug incompatibility chemistry","volume":"66","author":"Newton","year":"2009","journal-title":"Am J Health-system Pharmacy"},{"key":"10.1016\/j.jaip.2022.06.030_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2133.2008.08875.x","article-title":"Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins","volume":"160","author":"Lopez","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.06.030_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0536.1996.tb02293.x","article-title":"Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids","volume":"35","author":"Boehncke","year":"1996","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.06.030_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0536.1998.tb05823.x","article-title":"Intravenous challenge with heparins in patients with delayed-type skin reactions after subcutaneous administration of the drug","volume":"39","author":"Trautmann","year":"1998","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.06.030_bib28","first-page":"249","article-title":"Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration","volume":"43","author":"Irion","year":"2000","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.06.030_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1034\/j.1600-0536.2002.460106.x","article-title":"Arthus reaction to lepirudin, a new recombinant hirudin, and delayed-type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administration","volume":"46","author":"Jappe","year":"2002","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.06.030_bib30","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1445-1433.2004.03233.x","article-title":"Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration","volume":"74","author":"Liew","year":"2004","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.jaip.2022.06.030_bib31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2141.2004.05321.x","article-title":"Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study","volume":"128","author":"Gaigl","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2022.06.030_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1710-1492-7-7","article-title":"The concept of \u201ccompartment allergy\u201d: prilocaine injected into different skin layers","volume":"7","author":"Wobser","year":"2011","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2022.06.030_bib33","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1398-9995.2009.02082.x","article-title":"Effector and regulatory mechanisms in allergic contact dermatitis","volume":"64","author":"Vocanson","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.06.030_bib34","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1002\/eji.200636207","article-title":"CD4+ CD25+ regulatory T\u00a0cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue","volume":"36","author":"Ring","year":"2006","journal-title":"Eur J Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822006535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822006535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:34:31Z","timestamp":1761975271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822006535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2213219822006535"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.06.030","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed-Type Heparin Allergy: Intravenous Tolerance Despite Inflammatory Skin Reaction After Subcutaneous Injection","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}